首页> 外文期刊>有機合成化学協会誌 >Research and Process Development of Cefditoren Pivoxil: an Oral Cephalosporin Antibiotic
【24h】

Research and Process Development of Cefditoren Pivoxil: an Oral Cephalosporin Antibiotic

机译:Cefditoren Pivoxil的研究与过程开发:口腔孢子酸抗生素

获取原文
获取原文并翻译 | 示例
           

摘要

Cefditoren Pivoxil was synthesized in the course of study on a series of cephalosporins having various heterocycles attached to the C3-position of the cephem nucleus through Z-and E-etheno groups. Introduction of the side chains to the cephalosporins was achieved by a Wittig reaction. The reaction showed rather poor Z-E selectivity (Z:E = 1:1 to 4:1) in the stage of screening research. Investigation was started for improvement of the Z-selectivity soon after determining Cefditoren Pivoxil as a development candidate substance, and relatively high Z-selectivity (Z:E = 94:6) was finally achieved. The overall yield of Cefditoren Pivoxil was 49.6% in the established manufacturing synthetic method. Cefditoren, the active form of Cefditoren Pivoxil, has remarkably potent activity to penicillin-resistant Streptococcus pneumoniae (PRSP) and #beta#-lactamase-negative-ampicillin resistant Haemophilus influenzae (BLNAR) among the oral #beta#-lactam antibiotics.
机译:Cefditoren Pivoxil在研究中合成的在Z-和E-乙烯基团上具有附着在心肌核的C3位置的各种杂环的一系列头孢菌素的过程中。 通过Wittig反应实现侧链的侧链。 在筛选研究的阶段,反应显示出相当较差的Z-E选择性(Z:E = 1:1至4:1)。 在将Cefditoren Pivoxil作为显影候选物质确定Cefditoren Pivoxil之后,开始研究Z选择性,最终实现了相对较高的Z选择性(Z:E = 94:6)。 在已建立的制造合成方法中,Cefditoren Pivoxil的总产量为49.6%。 Cefditoren是Cefditoren Pivoxil的活性形式,对青霉素抗性链球菌(PRSP)和#β#-β-酰胺酶 - 阴性 - 氨苄青霉素(Beta#-lactamase阴性 - 氨苄青霉素(Blnar)之间具有显着的活性活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号